Empresa Freeline Therapeutics Holdings plc
Acciones
FRLN
US35655L2060
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 152
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Markus Hörer
FOU | Founder | - | 01/01/15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16/05/22 |
Chief Tech/Sci/R&D Officer | 57 | 01/03/22 | |
Pamela Foulds
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/11/21 |
James Bircher
COO | Chief Operating Officer | 56 | 01/07/21 |
Naomi Aoki
IRC | Investor Relations Contact | - | - |
Chip McCorkle
LAW | General Counsel | - | - |
Nicole Jones
HRO | Human Resources Officer | 54 | 11/07/22 |
Amy J. Spandau
PRN | Corporate Officer/Principal | - | 01/02/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chris Hollowood
CHM | Chairman | 50 | 01/12/15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16/05/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 65 369 417 | 64 715 513 ( 99,00 %) | 0 | 99,00 % |
Información de la empresa
Freeline Therapeutics Holdings Plc
Sycamore House Gunnels Wood Road
SG1 2BP, Stevenage
+44 14 3890 6870
http://www.freeline.lifeSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,96 % | 105 mil M | |
-1,43 % | 104 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+6,79 % | 14,16 mil M | |
+38,61 % | 12,63 mil M |